Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Andorra
Andorra: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 93.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Andorra, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Andorra is 93.0%, measured in 2025.
Compared with earlier readings it is down 3.1% on the previous year and up 1.1% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Andorra peaked at 98.0% in 2017 and was at its lowest, 0.0%, in 2008.
Andorra ranks 53rd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 56.5% | 0.0% | 98.0% | 10 |
| 2020s | 94.8% | 93.0% | 96.0% | 6 |
Countries ranked near Andorra
More health data for Andorra
- Heat deaths vs projected death rates 1,824 (2090)
- Un projection of annual infant deaths 0 (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age population, age 09, male, interpolated 371 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
- Age population, age 06, female, interpolated 266 (2025)
- Population, male 42,360 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Andorra?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Andorra was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Andorra?
- The highest recorded value was 98.0% in 2017.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Andorra?
- The lowest recorded value was 0.0% in 2008.
- How does Andorra rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Andorra ranks 53rd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Andorra?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is volatile.
- Where does this Andorra data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).